97 Recruiting Myelodysplastic Syndrome Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Related Conditions
Top Recruiting Myelodysplastic Syndrome Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
📍 Memorial Sloan Kettering Basking Ridge (Consent Only) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol
Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?
📍 Juravinski Hospital and Cancer Centre — Hamilton, Ontario
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
📍 Alta Bates Summit Medical Center-Herrick Campus — Berkeley, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔